48 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
efforts, detailing, advertising, market research, market access (including price and reimbursement activities), marketing, and sales (including receiving … with reasonable access during normal business hours and upon reasonable advance request to the books and records of Parent Group to the extent
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours … stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
& Rosati P.C. (“Wilson Sonsini”) with access to a virtual data room containing diligence materials.
Between March 18, 2023, and April 15, 2023 … may, in certain circumstances (i) furnish information or access thereto to a third party making such a Company Acquisition Proposal and (ii
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
Company Acquisition Proposals; Company Change in Recommendation
Regulatory Approvals and Related Matters
Access; Consultation
Stock Exchange De-listing … Effect. There is no, and has been no, breach, security incident, or accidental, unlawful, or unauthorized access to, or other Processing of, Company
8-K
EX-10.1
75jdx7
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.2
y24adt 7a2s0lox6
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
8-K
EX-1.1
xodmjlqj3ojad6puik
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
ukfwhk6
3 Nov 22
Prospectus supplement for primary offering
4:42pm